Tag: Numinus Wellness
Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders
Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council
Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory
Numinus Announces Closing of Oversubscribed $4.6 Million Offering
Numinus Files Restated Financial Reports
CORRECTION: Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms
